Leanabl Logo

Korea · Regulatory Strategy

Definitive Korean Market Entry Regulatory Roadmap

Lock in MFDS classification, predicate equivalence, testing scope, and KGMP audit tracks upfront to eliminate regulatory risk and sunk costs.

Domain Expertise

Deep regulatory authority across every medical device domain

SaMD · AI Digital Health

IEC 62304 · Software Lifecycle · MFDS AI/Big Data & DTx Guidance

Prevented Class III re-classification by establishing valid predicate equivalence, reducing approval time by 8 months.

Active Devices · Robotics

IEC 60601-1 / 60601-1-2 (Ed. 4.1) · IEC 60601-2-XX Particular Standards

Architected regulatory positioning under the Digital Medical Products Act, unlocking expedited integrated review.

Implants · Biomaterials

ISO 10993-1 to 23 Biocompatibility · ISO 11135 / 11137 Sterilization Validation

Biological endpoint matrix design and ISO 10993-18 chemical characterization / toxicological assessment

In Vitro Diagnostics (IVD)

Korea IVD Act & EU IVDR (2017/746) · CLSI EP Guidelines (EP05, EP06, EP12, EP17)

CLSI-compliant Limit of Detection (LoD), cross-reactivity, interference, and lot-to-lot reproducibility protocols

Proprietary Data & Precedent Validation

Empirical Validation via Predicate & Regulatory Databases

100% Cross-Validated Predicate & Classification Intelligence

Engineered 4-Stage Workflow

A Standardized 4-Stage Pipeline from Intake to Masterplan

Step 01 / 04Stage Gate & Output

Locked Technical Baseline & Intended Use

Incomplete baseline data or misclassified regulatory pathways are the primary drivers of multi-month submission delays. Gate 01 locks the device scope, predicate/standard mapping, and full document inventory before authoring begins.

Verification Baseline

Device description, intended use, existing test reports, and QMS document index

Gate Sign-Off Output

Confirmed classification matrix and locked submission master inventory

Agentic Automation & Platform Integration

From Static Strategy Decks to Live Platform Execution

Automated Requirement Traceability

Directly link confirmed regulatory standards and testing requirements into PLM and risk management modules.

@Requirements Management— Run "Automated Requirement Traceability" across our Regulatory Strategy records and call out the highest-priority compliance findings first.

I'll inspect the linked quality and dossier records against target regulatory standards, then report actionable findings with verified outputs.

Thought for 4.2s · Explored Requirements Management records & 14 regulatory clauses

P1 · Verified Agent Output· Locked Technical Baseline & Intended Use

Directly link confirmed regulatory standards and testing requirements into PLM and risk management modules. Traceability from specification to verification

Structured Predicate & Dossier Seeding

Convert validated equivalence matrices directly into pre-populated technical submission templates.

@Risk Management— Run "Structured Predicate & Dossier Seeding" across our Regulatory Strategy records and call out the highest-priority compliance findings first.

I'll inspect the linked quality and dossier records against target regulatory standards, then report actionable findings with verified outputs.

Thought for 4.3s · Explored Risk Management records & 14 regulatory clauses

P1 · Verified Agent Output· Live Milestone & Critical-Path Tracking

Monitor testing, GMP, and submission dependencies in one unified RIM workspace with zero handoff loss. ISO 14971 risk register linked to design control

Service Specification

Service Scope & Final Deliverables

Scope

We establish regulatory qualification, classification, the optimal submission track, and core evidentiary requirements.

  • Regulatory qualification — medical device / IVD / digital health (SaMD)
  • Target classification and grade, combination-device and kit determination
  • Submission track and reviewing body — notification, certification, approval, or expedited pathways
  • Predicate device identification and technical equivalence comparison
  • Clinical evidence exemption analysis and testing gap assessment (performance, electrical, biocompatibility, cybersecurity)

Deliverables

Every conclusion cites regulatory statutes and predicate precedents, delivered in an executive summary and technical dossier.

  • Regulatory qualification determination memo and classification review
  • Predicate device equivalence matrix and benchmark report
  • Submission pathway decision table and expedited-track eligibility assessment
  • Evidence requirement gap matrix and testing checklist
  • Step-by-step commercial timeline, itemized budget estimate, and regulatory risk register
Regulatory Strategy — Service Scope & Final Deliverables
CategoryItem / MilestoneSpecification & Deliverable
ScopeScope 1Regulatory qualification — medical device / IVD / digital health (SaMD)
ScopeScope 2Target classification and grade, combination-device and kit determination
ScopeScope 3Submission track and reviewing body — notification, certification, approval, or expedited pathways
ScopeScope 4Predicate device identification and technical equivalence comparison
ScopeScope 5Clinical evidence exemption analysis and testing gap assessment (performance, electrical, biocompatibility, cybersecurity)
WorkflowStage 1: Technical Intake & Architecture FreezeLock down intended use, mechanism of action, materials, sterility, and software architecture through in-depth technical review.
WorkflowStage 2: Regulatory Cross-ValidationInterrogate target regulatory databases (MFDS, FDA, EU MDR), statutory classification rules, and predicate equivalence with senior peer review.
WorkflowStage 3: Pathway & Evidence SequencingMap submission tracks, laboratory testing lead times, clinical evidence thresholds, GMP inspection timing, and reimbursement milestones chronologically.
WorkflowStage 4: Executive Masterplan & BriefingDeliver the decision-ready Pathway Report detailing classification, predicate defense, itemized budget, and conduct leadership briefing for sign-off.
DeliverablesDeliverable 1Regulatory qualification determination memo and classification review
DeliverablesDeliverable 2Predicate device equivalence matrix and benchmark report
DeliverablesDeliverable 3Submission pathway decision table and expedited-track eligibility assessment
DeliverablesDeliverable 4Evidence requirement gap matrix and testing checklist
DeliverablesDeliverable 5Step-by-step commercial timeline, itemized budget estimate, and regulatory risk register

Frequently Asked Questions

Yes. MFDS maintains independent classification rules. Without a qualified domestic predicate, foreign Class II devices frequently require Class III review.

Yes. 100% of the strategic advisory fee is credited toward subsequent technical file or KGMP turnkey execution engagements.

Upon receiving any deficiency notice from MFDS or a review body, our specialists dissect the reviewer’s statutory intent against historical clearance precedents. We separate items resolvable via technical justification from those requiring supplementary bench data, draft the complete formal response package, and manage reviewer alignment through final closure.

Yes. However, direct translation without regulatory reconciliation frequently triggers rejections due to standard edition mismatches or Korea National Deviations. We map your existing IECEE CB / ILAC test reports and global dossiers 1:1 against MFDS recognized standards to maximize evidence reuse and avoid redundant laboratory testing.

Our workflow is engineered to minimize engineering disruption. Once your team provides baseline source files (specifications, BOM, existing reports) during Stage 1 intake, Leanabl handles the heavy lifting: statutory mapping, Korean regulatory authoring, traceability matrix compilation, electronic portal filing, and agency correspondence. Your team only reviews and signs off at structured stage gates.

We immediately perform a regulatory change impact assessment to determine whether the modification requires a formal Technical File amendment, minor notification, or internal QMS documentation update. Because all deliverables are structured into modular digital assets, subsequent design iterations only require updating the affected sections rather than rebuilding the dossier from scratch.

Ready to Accelerate Your Korean Regulatory Pathway?

Built on our proprietary MFDS review database, our next-generation regulatory system compresses turnaround times to 1/5 and systematically prevents recurring deficiency cycles.